O Asghar1, P Arumugam2, I S Armstrong2, S G Ray3, M Schmitt3, R A Malik4,5. 1. Institute of Cardiovascular Sciences, University of Manchester & Manchester Heart Centre, Central Manchester Foundation Trust, Manchester, United Kingdom. omar.asghar@manchester.ac.uk. 2. Department of Nuclear Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom. 3. North West Heart and Transplant Centre, University Hospital of South Manchester, Manchester, United Kingdom. 4. Centre for Endocrinology & Diabetes, Institute of Human Development, University of Manchester, Manchester, United Kingdom. Rayaz.A.Malik@manchester.ac.uk. 5. Weill Cornell Medical College, Doha, Qatar. Rayaz.A.Malik@manchester.ac.uk.
Abstract
BACKGROUND: Impaired glucose tolerance (IGT) is associated with an increased risk of type 2 diabetes (T2DM) and cardiovascular disease. Some but not all studies have reported cardiac autonomic dysfunction in subjects with IGT and there is only one direct study of cardiac innervation in subjects with IGT. The purpose of this study was to assess global and regional cardiac sympathetic innervation and cardiac autonomic function in individuals with IGT. METHODS AND RESULTS: We undertook (123)I-mIBG scintigraphy and cardiac autonomic function in 15 subjects with IGT and 15 age and sex-matched healthy controls. Early heart to mediastinum ratio (HMR) (1.71 ± 0.17 vs 1.67 ± 0.13, P = .49), late HMR (1.73 ± 0.18 vs 1.73 ± 0.16, P = .97) and washout rate (WR) (18.6 ± 4.2 vs 19.1 ± 7.6%, P = .84), did not differ between subjects with IGT and control subjects. More detailed regional analysis revealed reduced tracer uptake at the apex, base and inferior wall in all subjects and the anterior wall in a minority of subjects. There were no differences in total score (56.6 ± 4.0 vs 53.3 ± 8.4, P = .193), modified score (48.5 ± 3.3 vs 46.2 ± 6.0, P = .215), anterior wall score (10.2 ± 1.3 vs 10.1 ± 1.6, P = .898), inferior wall score (8.9 ± 1.9 vs 7.7 ± 2.6, P = .163), basal score (18.7 ± 1.9 vs 18.2 ± 3.3, P = .636) and tests of cardiac autonomic function between the groups. CONCLUSION: Global and regional measures of MIBG uptake and washout as well as cardiac autonomic function did not differ between subjects with IGT and healthy controls.
BACKGROUND:Impaired glucose tolerance (IGT) is associated with an increased risk of type 2 diabetes (T2DM) and cardiovascular disease. Some but not all studies have reported cardiac autonomic dysfunction in subjects with IGT and there is only one direct study of cardiac innervation in subjects with IGT. The purpose of this study was to assess global and regional cardiac sympathetic innervation and cardiac autonomic function in individuals with IGT. METHODS AND RESULTS: We undertook (123)I-mIBG scintigraphy and cardiac autonomic function in 15 subjects with IGT and 15 age and sex-matched healthy controls. Early heart to mediastinum ratio (HMR) (1.71 ± 0.17 vs 1.67 ± 0.13, P = .49), late HMR (1.73 ± 0.18 vs 1.73 ± 0.16, P = .97) and washout rate (WR) (18.6 ± 4.2 vs 19.1 ± 7.6%, P = .84), did not differ between subjects with IGT and control subjects. More detailed regional analysis revealed reduced tracer uptake at the apex, base and inferior wall in all subjects and the anterior wall in a minority of subjects. There were no differences in total score (56.6 ± 4.0 vs 53.3 ± 8.4, P = .193), modified score (48.5 ± 3.3 vs 46.2 ± 6.0, P = .215), anterior wall score (10.2 ± 1.3 vs 10.1 ± 1.6, P = .898), inferior wall score (8.9 ± 1.9 vs 7.7 ± 2.6, P = .163), basal score (18.7 ± 1.9 vs 18.2 ± 3.3, P = .636) and tests of cardiac autonomic function between the groups. CONCLUSION: Global and regional measures of MIBG uptake and washout as well as cardiac autonomic function did not differ between subjects with IGT and healthy controls.
Authors: Raghava S Velagaleti; Philimon Gona; Michael L Chuang; Carol J Salton; Caroline S Fox; Susan J Blease; Susan B Yeon; Warren J Manning; Christopher J O'Donnell Journal: Circ Cardiovasc Imaging Date: 2010-03-05 Impact factor: 7.792
Authors: M J Stevens; D M Raffel; K C Allman; F Dayanikli; E Ficaro; T Sandford; D M Wieland; M A Pfeifer; M Schwaiger Journal: Circulation Date: 1998-09-08 Impact factor: 29.690
Authors: Nora E Straznicky; Mariee T Grima; Carolina I Sari; Nina Eikelis; Elisabeth A Lambert; Paul J Nestel; Murray D Esler; John B Dixon; Reena Chopra; Alan J Tilbrook; Markus P Schlaich; Gavin W Lambert Journal: Diabetes Date: 2012-06-04 Impact factor: 9.461
Authors: Omar Asghar; Ioannis N Petropoulos; Uazman Alam; Wendy Jones; Maria Jeziorska; Andrew Marshall; Georgios Ponirakis; Hassan Fadavi; Andrew J M Boulton; Mitra Tavakoli; Rayaz A Malik Journal: Diabetes Care Date: 2014-06-26 Impact factor: 19.112
Authors: G Roberts; J J Lloyd; J P M Kane; R Durcan; S Lawley; K Howe; G S Petrides; J T O'Brien; A J Thomas Journal: J Nucl Cardiol Date: 2019-09-16 Impact factor: 5.952
Authors: Shazli Azmi; Maryam Ferdousi; Yifen Liu; Safwaan Adam; Tarza Siahmansur; Georgios Ponirakis; Andrew Marshall; Ioannis N Petropoulos; Jan Hoong Ho; Akheel A Syed; John M Gibson; Basil J Ammori; Paul N Durrington; Rayaz A Malik; Handrean Soran Journal: Sci Rep Date: 2021-06-15 Impact factor: 4.379
Authors: Charikleia Stefanaki; Athanasios Michos; George Latsios; Dimitrios Tousoulis; Melpomeni Peppa; Paraskevi Zosi; Dario Boschiero; Flora Bacopoulou Journal: Int J Environ Res Public Health Date: 2020-04-14 Impact factor: 3.390